{"id":42349,"date":"2024-03-11T15:52:31","date_gmt":"2024-03-11T15:52:31","guid":{"rendered":"https:\/\/www.elza-institute.com\/?p=42349"},"modified":"2025-11-18T08:01:52","modified_gmt":"2025-11-18T08:01:52","slug":"osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking","status":"publish","type":"post","link":"https:\/\/www.elza-institute.com\/pt\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/","title":{"rendered":"A OSN informa sobre os mais recentes avan\u00e7os da ELZA em epi-on crosslinking"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"42349\" class=\"elementor elementor-42349\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6e5f48de e-flex e-con-boxed e-con e-parent\" data-id=\"6e5f48de\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-768f4546 elementor-widget elementor-widget-text-editor\" data-id=\"768f4546\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Num artigo recente, <a href=\"https:\/\/www.healio.com\/news\/ophthalmology\/20240226\/video-epion-crosslinking-moving-out-of-operating-room\">Not\u00edcias de Cirurgia Ocular<\/a> (OSN) forneceu uma panor\u00e2mica aprofundada dos \u00faltimos avan\u00e7os na reticula\u00e7\u00e3o epi-on, tal como apresentado por <a href=\"https:\/\/www.elza-institute.com\/pt\/sobre\/farhad-hafezi\/\">Prof. Farhad Hafezi<\/a> do Instituto ELZA na reuni\u00e3o de inverno da ESCRS em Frankfurt, Alemanha. O relat\u00f3rio salienta os progressos significativos registados no desenvolvimento e aperfei\u00e7oamento das t\u00e9cnicas de epi-on crosslinking para o tratamento do ceratocone e da ectasia da c\u00f3rnea.<\/p><p>Introduzido em 2009, o epi-on CXL ofereceu o potencial para um tratamento menos invasivo das doen\u00e7as da c\u00f3rnea, com benef\u00edcios como a redu\u00e7\u00e3o do desconforto do doente e tempos de recupera\u00e7\u00e3o mais r\u00e1pidos em compara\u00e7\u00e3o com o m\u00e9todo tradicional epi-off. No entanto, as itera\u00e7\u00f5es iniciais do procedimento depararam-se com obst\u00e1culos no fornecimento eficiente de oxig\u00e9nio e riboflavina, essenciais para o sucesso do tratamento.<\/p><p>Hafezi, juntamente com outros investigadores, trabalhou na racionaliza\u00e7\u00e3o do processo. A nova abordagem ao epi-on CXL simplifica o procedimento, exigindo apenas o paciente, uma l\u00e2mpada de fenda e gotas oculares, afastando-se da depend\u00eancia de tanques de oxig\u00e9nio, \u00f3culos de prote\u00e7\u00e3o e dispositivos de iontoforese anteriormente associados aos tratamentos epi-on.<\/p><p>Na cobertura da OSN, o Prof. Hafezi discute os testes abrangentes da efic\u00e1cia biomec\u00e2nica desta t\u00e9cnica epi-on evolu\u00edda, indicando resultados compar\u00e1veis \u00e0 abordagem epi-off convencional. O Instituto ELZA dever\u00e1 publicar dados cl\u00ednicos pormenorizados no final do ano, esclarecendo a efic\u00e1cia e a seguran\u00e7a do procedimento.<\/p><p>Esta evolu\u00e7\u00e3o do epi-on crosslinking significa uma mudan\u00e7a no sentido de modalidades de tratamento da c\u00f3rnea mais centradas no doente. Ao reduzir a complexidade e o equipamento necess\u00e1rio para o procedimento, o objetivo \u00e9 tornar o tratamento mais acess\u00edvel a uma popula\u00e7\u00e3o mais vasta de doentes.<\/p><p>O esfor\u00e7o cont\u00ednuo do Instituto ELZA para inovar no campo da oftalmologia \u00e9 destacado atrav\u00e9s destes avan\u00e7os. Com a comunidade oftalmol\u00f3gica a aguardar ansiosamente a publica\u00e7\u00e3o dos resultados cl\u00ednicos do Instituto, os desenvolvimentos em epi-on crosslinking representam um momento crucial na melhoria cont\u00ednua dos protocolos de tratamento de doen\u00e7as da c\u00f3rnea.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-d649214 e-flex e-con-boxed e-con e-parent\" data-id=\"d649214\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8c970b3 elementor-widget elementor-widget-text-editor\" data-id=\"8c970b3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Transcri\u00e7\u00e3o<\/strong>:<br \/>Fala Farhad Hafezi, da Su\u00ed\u00e7a, e estamos atualmente na reuni\u00e3o de inverno da ESCRS em Frankfurt, Alemanha. Esta manh\u00e3, fiz uma apresenta\u00e7\u00e3o sobre o epi-on cross-linking da ELZA. Todos sabemos que o epi-On existe desde 2009, e o in\u00edcio foi um pouco acidentado porque a tecnologia n\u00e3o estava onde deveria estar. As promessas n\u00e3o puderam ser cumpridas no in\u00edcio. Desde 2019 que temos o epi-on a funcionar, mas a t\u00e9cnica tornou-se bastante volumosa, com botijas de oxig\u00e9nio, \u00f3culos de oxig\u00e9nio e dispositivos de iontoforese. Desde 2019, o meu grupo e outros tentaram eliminar a necessidade de fornecer oxig\u00e9nio e riboflavina atrav\u00e9s da iontoforese. E, finalmente, conseguimos agora ter um Epi-on que s\u00f3 precisa do doente, de uma l\u00e2mpada de fenda e de gotas oculares. Acabou-se a botija de oxig\u00e9nio e a iontoforese. Test\u00e1mos a biomec\u00e2nica. \u00c9 t\u00e3o bom como o epi-off de 10 minutos. E vamos publicar os nossos dados cl\u00ednicos este ano. Not\u00edcias muito interessantes: a epinefrina de consult\u00f3rio pode sair do bloco operat\u00f3rio.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Num artigo recente, a Ocular Surgery News (OSN) forneceu uma vis\u00e3o geral aprofundada dos \u00faltimos avan\u00e7os em epi-on crosslinking, tal como apresentado pelo Prof. Farhad Hafezi do Instituto ELZA na reuni\u00e3o de inverno da ESCRS em Frankfurt, Alemanha.<\/p>","protected":false},"author":4,"featured_media":42355,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[214,1,96,10],"tags":[125,810,809,561,806,130,100,679,134,805,637,361,123,808,807,866],"class_list":["post-42349","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-farhad-hafezi","category-general-news","category-popular-press","category-video-interviews","tag-cornea","tag-corneal-crosslinking-research","tag-corneal-disease-treatment","tag-corneal-ectasia","tag-corneal-treatment","tag-cross-linking","tag-cxl","tag-elza-institute","tag-epi-on","tag-epi-on-crosslinking","tag-epi-on-cxl","tag-farhad-hafezi","tag-keratoconus","tag-ocular-surgery-news","tag-ophthalmology-advancements","tag-video-interview"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>OSN reports on ELZA latest advancements in epi-on crosslinking<\/title>\n<meta name=\"description\" content=\"&quot;Overview of ELZA&#039;s epi-on crosslinking progress, as reported by OSN, with ELZA&#039;s latest innovations in bringing simple epi-on to the clinic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.elza-institute.com\/pt\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OSN reports on ELZA latest advancements in epi-on crosslinking\" \/>\n<meta property=\"og:description\" content=\"&quot;Overview of ELZA&#039;s epi-on crosslinking progress, as reported by OSN, with ELZA&#039;s latest innovations in bringing simple epi-on to the clinic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.elza-institute.com\/pt\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/\" \/>\n<meta property=\"og:site_name\" content=\"The ELZA Institute\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ELZA.Institute\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-11T15:52:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-18T08:01:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/03\/osn-feb-epi-on-2024.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mark Hillen\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark Hillen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/\"},\"author\":{\"name\":\"Mark Hillen\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15\"},\"headline\":\"OSN reports on ELZA latest advancements in epi-on crosslinking\",\"datePublished\":\"2024-03-11T15:52:31+00:00\",\"dateModified\":\"2025-11-18T08:01:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/\"},\"wordCount\":469,\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/03\/osn-feb-epi-on-2024.jpg\",\"keywords\":[\"Cornea\",\"corneal crosslinking research\",\"corneal disease treatment\",\"corneal ectasia\",\"corneal treatment\",\"Cross-Linking\",\"CXL\",\"ELZA Institute\",\"epi-on\",\"epi-on crosslinking\",\"Epi-on CXL\",\"Farhad Hafezi\",\"Keratoconus\",\"ocular surgery news\",\"ophthalmology advancements\",\"Video Interview\"],\"articleSection\":[\"Farhad Hafezi\",\"News\",\"Popular press\",\"Video Interview\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/\",\"url\":\"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/\",\"name\":\"OSN reports on ELZA latest advancements in epi-on crosslinking\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/03\/osn-feb-epi-on-2024.jpg\",\"datePublished\":\"2024-03-11T15:52:31+00:00\",\"dateModified\":\"2025-11-18T08:01:52+00:00\",\"description\":\"\\\"Overview of ELZA's epi-on crosslinking progress, as reported by OSN, with ELZA's latest innovations in bringing simple epi-on to the clinic.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#primaryimage\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/03\/osn-feb-epi-on-2024.jpg\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/03\/osn-feb-epi-on-2024.jpg\",\"width\":1200,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.elza-institute.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\/\/www.elza-institute.com\/general-news\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"OSN reports on ELZA latest advancements in epi-on crosslinking\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.elza-institute.com\/#website\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"name\":\"The ELZA Institute\",\"description\":\"Swiss EyeCare at its finest\",\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.elza-institute.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.elza-institute.com\/#organization\",\"name\":\"The ELZA Institute\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"width\":1181,\"height\":453,\"caption\":\"The ELZA Institute\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ELZA.Institute\/\",\"https:\/\/x.com\/ELZA_Institute\",\"https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15\",\"name\":\"Mark Hillen\",\"url\":\"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A OSN informa sobre os mais recentes avan\u00e7os da ELZA em epi-on crosslinking","description":"\"Vis\u00e3o geral do progresso da reticula\u00e7\u00e3o epi-on da ELZA, conforme relatado pela OSN, com as mais recentes inova\u00e7\u00f5es da ELZA na introdu\u00e7\u00e3o do epi-on simples na cl\u00ednica.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.elza-institute.com\/pt\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/","og_locale":"pt_PT","og_type":"article","og_title":"OSN reports on ELZA latest advancements in epi-on crosslinking","og_description":"\"Overview of ELZA's epi-on crosslinking progress, as reported by OSN, with ELZA's latest innovations in bringing simple epi-on to the clinic.","og_url":"https:\/\/www.elza-institute.com\/pt\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/","og_site_name":"The ELZA Institute","article_publisher":"https:\/\/www.facebook.com\/ELZA.Institute\/","article_published_time":"2024-03-11T15:52:31+00:00","article_modified_time":"2025-11-18T08:01:52+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/03\/osn-feb-epi-on-2024.jpg","type":"image\/jpeg"}],"author":"Mark Hillen","twitter_misc":{"Escrito por":"Mark Hillen","Tempo estimado de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#article","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/"},"author":{"name":"Mark Hillen","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15"},"headline":"OSN reports on ELZA latest advancements in epi-on crosslinking","datePublished":"2024-03-11T15:52:31+00:00","dateModified":"2025-11-18T08:01:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/"},"wordCount":469,"publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"image":{"@id":"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/03\/osn-feb-epi-on-2024.jpg","keywords":["Cornea","corneal crosslinking research","corneal disease treatment","corneal ectasia","corneal treatment","Cross-Linking","CXL","ELZA Institute","epi-on","epi-on crosslinking","Epi-on CXL","Farhad Hafezi","Keratoconus","ocular surgery news","ophthalmology advancements","Video Interview"],"articleSection":["Farhad Hafezi","News","Popular press","Video Interview"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/","url":"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/","name":"A OSN informa sobre os mais recentes avan\u00e7os da ELZA em epi-on crosslinking","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#primaryimage"},"image":{"@id":"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/03\/osn-feb-epi-on-2024.jpg","datePublished":"2024-03-11T15:52:31+00:00","dateModified":"2025-11-18T08:01:52+00:00","description":"\"Vis\u00e3o geral do progresso da reticula\u00e7\u00e3o epi-on da ELZA, conforme relatado pela OSN, com as mais recentes inova\u00e7\u00f5es da ELZA na introdu\u00e7\u00e3o do epi-on simples na cl\u00ednica.","breadcrumb":{"@id":"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#primaryimage","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/03\/osn-feb-epi-on-2024.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/03\/osn-feb-epi-on-2024.jpg","width":1200,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.elza-institute.com\/osn-reports-on-elzas-latest-advancements-in-epi-on-crosslinking\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.elza-institute.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.elza-institute.com\/general-news\/"},{"@type":"ListItem","position":3,"name":"OSN reports on ELZA latest advancements in epi-on crosslinking"}]},{"@type":"WebSite","@id":"https:\/\/www.elza-institute.com\/#website","url":"https:\/\/www.elza-institute.com\/","name":"O Instituto ELZA","description":"Swiss EyeCare no seu melhor","publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.elza-institute.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/www.elza-institute.com\/#organization","name":"O Instituto ELZA","url":"https:\/\/www.elza-institute.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","width":1181,"height":453,"caption":"The ELZA Institute"},"image":{"@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ELZA.Institute\/","https:\/\/x.com\/ELZA_Institute","https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home"]},{"@type":"Person","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15","name":"Mark Hillen","url":"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/42349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/comments?post=42349"}],"version-history":[{"count":0,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/42349\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media\/42355"}],"wp:attachment":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media?parent=42349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/categories?post=42349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/tags?post=42349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}